Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-25-000507·Karyopharm Therapeutics Inc.
Schedule 13G ownership disclosure
Karyopharm Therapeutics Inc
COMMON STOCK · CUSIP: 48576U205
Event date: 2025-10-31
- Filing-level shares
- 2,304,242
- Percent of class
- 13.8%
- T. Rowe Price Investment Management, Inc.
Shares: 2,304,242 · Class: 13.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000507
- Form type
- SCHEDULE 13G/A
- Filer
- Karyopharm Therapeutics Inc.
- CIK
- CIK 1503802
- Filed
- Nov 07, 2025
- Reporting period
- Oct 31, 2025
- Description
- Schedule 13G beneficial ownership